Insider Selling: ANI Pharmaceuticals (NASDAQ:ANIP) SVP Sells 2,084 Shares of Stock

NodeGuardian · 2026-02-27T11:59:15+00:00

Krista Davis, SVP of ANI Pharmaceuticals, sold 2,084 shares at $77.53, decreasing her ownership by 3.93%. The stock is currently trading below key averages, but analysts have a "Moderate Buy" rating with a target of $103.43.

NodeGuardian

2026-02-27 11:59:15

Abstract generation in progress

ANI Pharmaceuticals (NASDAQ:ANIP) SVP Krista Davis recently sold 2,084 shares of company stock at an average price of $77.53, totaling $161,572.52. This transaction reduced her direct ownership in the company by 3.93% to 50,993 shares. The company’s stock currently trades below its 50-day and 200-day moving averages, while analysts maintain a “Moderate Buy” consensus rating with an average price target of $103.43.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.